by Bruce Sylvester – taken from the NEJM (New England Journal of Medicine) – Addition of nab-paclitaxel to gemcitabine for treatment of advanced pancreatic cancer has resulted in… read more.
by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.
17th ECCO – 38th ESMO – 32nd ESTRO – European Cancer Congress, Amsterdam RAI, 27 Sept – 1 Oct 2013. Eribulin represents a novel class of antineoplastic agents… read more.
A major new publication from the European Respiratory Society (ERS) ahead of its annual congress, shows that lung conditions are responsible for 1 in 10 of all deaths… read more.
EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has a new member: Ivana Mikacic has been nominated by Croatia which… read more.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.
by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
Greater sensitivity, with lower radiation dose, allows for faster treatment, reported at 93rd AATS Annual Meeting. Lung cancer is associated with very high mortality, in part because it… read more.
by Maria Dalby reporting on the presentation by Rajeev Desai, National Health Service Blood and Transplant, Bristol. The risk of cancer transmission via transplanted organs is very low… read more.
Researchers have found that macrophages that play a key role in the immune response – also help to both produce and eliminate the body’s red blood cells (RBCs)…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
